These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 32776218

  • 1. Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Sokolenko AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, Iyevleva AG, Aleksakhina SN, Romanko AA, Bessonov AA, Gorodnova TV, Anisimova EI, Savonevich EL, Bizin IV, Stepanov IA, Krivorotko PV, Berlev IV, Belyaev AM, Togo AV, Imyanitov EN.
    Breast Cancer Res Treat; 2020 Nov; 184(1):229-235. PubMed ID: 32776218
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
    ElBiad O, Laraqui A, El Boukhrissi F, Mounjid C, Lamsisi M, Bajjou T, Elannaz H, Lahlou AI, Kouach J, Benchekroune K, Oukabli M, Chahdi H, Ennaji MM, Tanz R, Sbitti Y, Ichou M, Ennibi K, Badaoui B, Sekhsokh Y.
    BMC Cancer; 2022 Feb 25; 22(1):208. PubMed ID: 35216584
    [Abstract] [Full Text] [Related]

  • 3. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
    Ben Ayed-Guerfali D, Ben Kridis-Rejab W, Ammous-Boukhris N, Ayadi W, Charfi S, Khanfir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.
    J Transl Med; 2021 Mar 16; 19(1):108. PubMed ID: 33726785
    [Abstract] [Full Text] [Related]

  • 4. Non-founder BRCA1 mutations in Russian breast cancer patients.
    Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV, Kovalenko SP, Stoep Nv, Devilee P, Imyanitov EN.
    Cancer Lett; 2010 Dec 08; 298(2):258-63. PubMed ID: 20727672
    [Abstract] [Full Text] [Related]

  • 5. [Genotyping of BRCA1, BRCA2 and CHEK2 germline mutations in Russian breast cancer patients using diagnostic biochips].
    Nasedkina TV, Gromyko OE, Emel'ianova MA, Ignatova EO, Kazubskaia TP, Portnoĭ SM, Zasedatelev AS, Liubchenko LN.
    Mol Biol (Mosk); 2014 Dec 08; 48(2):243-50. PubMed ID: 25850293
    [Abstract] [Full Text] [Related]

  • 6. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling.
    Melki R, Melloul M, Aissaoui S, El Harroudi T, Boukhatem N.
    BMC Cancer; 2023 Apr 13; 23(1):339. PubMed ID: 37055759
    [Abstract] [Full Text] [Related]

  • 7. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer.
    Gaj P, Kluska A, Nowakowska D, Bałabas A, Piątkowska M, Dabrowska M, Niwińska A, Ostrowski J.
    Fam Cancer; 2012 Dec 13; 11(4):623-8. PubMed ID: 22864640
    [Abstract] [Full Text] [Related]

  • 8. [GENOTYPE-PHENOTYPE CORRELATIONS BY SPECIFIC FOUNDER VARIANTS IN BRCA IN ISRAELI WOMEN].
    Michaelson-Cohen R, Laitman Y, Kedar I, Baris-Feldman H, Reish O, Lieberman S, Bernstein-Molho R, Goldberg Y, Reznick Levi G, Gershoni R, Beller U, Levy-Lahad E, Catan R, Friedman E.
    Harefuah; 2023 Jun 13; 162(6):370-375. PubMed ID: 37394440
    [Abstract] [Full Text] [Related]

  • 9. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.
    Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D.
    Am J Hum Genet; 1997 May 13; 60(5):1059-67. PubMed ID: 9150153
    [Abstract] [Full Text] [Related]

  • 10. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update.
    Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubiński J, Cybulski C.
    Clin Genet; 2015 Mar 13; 87(3):288-92. PubMed ID: 24528374
    [Abstract] [Full Text] [Related]

  • 11. Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence.
    de Juan Jiménez I, García Casado Z, Palanca Suela S, Esteban Cardeñosa E, López Guerrero JA, Segura Huerta Á, Chirivella González I, Sánchez Heras AB, Juan Fita MJ, Tena García I, Guillen Ponce C, Martínez de Dueñas E, Romero Noguera I, Salas Trejo D, Goicoechea Sáez M, Bolufer Gilabert P.
    Fam Cancer; 2013 Dec 13; 12(4):767-77. PubMed ID: 23479189
    [Abstract] [Full Text] [Related]

  • 12. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
    Cherdyntseva NV, Pisareva LF, Ivanova AA, Panferova YV, Malinovskaya EA, Odintsova IN, Doroshenko AV, Gervas PA, Slonimskaya EM, Shivit-ool AA, Dvornichenko VV, Choinzonov YL.
    Vestn Ross Akad Med Nauk; 2014 Dec 13; (11-12):72-9. PubMed ID: 25971130
    [Abstract] [Full Text] [Related]

  • 13. Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?
    Nguyen-Dumont T, Karpinski P, Sasiadek MM, Akopyan H, Steen JA, Theys D, Hammet F, Tsimiklis H, Park DJ, Pope BJ, Slezak R, Stembalska A, Pesz K, Kitsera N, Siekierzynska A, Southey MC, Myszka A.
    Genet Res (Camb); 2020 Aug 10; 102():e6. PubMed ID: 32772980
    [Abstract] [Full Text] [Related]

  • 14. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?
    Teixeira N, van der Hout A, Oosterwijk JC, Vos JR, HEBON, Devilee P, van Engelen K, Meijers-Heijboer H, van der Luijt RB, Kriege M, Mensenkamp AR, Rookus MA, van Roozendaal KE, Mourits MJE, de Bock GH.
    Eur J Hum Genet; 2018 Jun 10; 26(6):848-857. PubMed ID: 29483665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
    Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E.
    Int J Cancer; 2000 Jun 01; 86(5):737-40. PubMed ID: 10797299
    [Abstract] [Full Text] [Related]

  • 17. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
    Górski B.
    Hered Cancer Clin Pract; 2006 Aug 15; 4(3):142-52. PubMed ID: 20223018
    [Abstract] [Full Text] [Related]

  • 18. Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations.
    Yanus GA, Savonevich EL, Sokolenko AP, Romanko AA, Ni VI, Bakaeva EK, Gorustovich OA, Bizin IV, Imyanitov EN.
    Fam Cancer; 2023 Jan 15; 22(1):19-30. PubMed ID: 35596902
    [Abstract] [Full Text] [Related]

  • 19. Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus.
    Sokolenko AP, Bakaeva EK, Venina AR, Kuligina ES, Romanko AA, Aleksakhina SN, Belysheva YV, Belogubova EV, Stepanov IA, Zaitseva OA, Yatsuk OS, Togo AV, Khamgokov ZM, Kadyrova AO, Pirmagomedov AS, Bolieva MB, Epkhiev AA, Tsutsaev AK, Chakhieva MD, Khabrieva KM, Khabriev IM, Murachuev MA, Buttaeva BN, Baboshkina LS, Bayramkulova FI, Katchiev IR, Alieva LK, Raskin GA, Orlov SV, Khachmamuk ZK, Levonyan KR, Gichko DM, Kirtbaya DV, Degtyariov AM, Sultanova LV, Musayeva HS, Belyaev AM, Imyanitov EN.
    Breast Cancer Res Treat; 2024 Jan 15; 203(2):307-315. PubMed ID: 37851290
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.